Viewing nowCombinationTelmisartan/Amlodipine Tablets 40/5 mg
Telmisartan 40mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Jinyang Pharmaceutical Co., Ltd.

MFDS item code 201606818 · Approved 2016.11.30 · Insurance code 650303600
Treatment of essential hypertension not controlled with monotherapy
This medication is used when blood pressure is not adequately controlled with telmisartan or amlodipine alone. It helps improve essential hypertension, which is a condition where blood pressure rises without a specific cause. Proper blood pressure management is crucial for reducing the risk of cardiovascular diseases and maintaining overall health, so this medication assists in controlling blood pressure.
The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended to take it at the same time each day (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted using the individual components (telmisartan or amlodipine). However, if blood pressure is not controlled with the individual components as follows, switching directly to this medicine may be considered. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this medicine 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. Patients taking telmisartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience (limited to this medicine 40/5 mg). ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. For patients with severe renal impairment, however, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Older adults: The usual amlodipine regimen is recommended for older adults, but caution should be exercised when increasing the dose (see section ‘3. Patients requiring careful administration’). In patients 75 years of age or older, amlodipine clearance is reduced; therefore, treatment should be started at a low dose and the dose increased gradually.
Pediatric patients 18 years of age or younger: The safety and efficacy of this medicine have not been established; therefore, its use is not recommended.
This medication should not be used in pregnant women, especially in the second and third trimesters, as it may pose serious risks to the fetus. It should not be administered to patients who are allergic to the active ingredient or similar substances, patients with severe liver impairment or obstructive biliary diseases, severe hypotension, or patients with significantly reduced cardiac function. Patients with primary aldosteronism, certain heart valve diseases, decreased liver function, gastrointestinal diseases, renal vascular diseases, those undergoing dialysis, and the elderly should use this medication with special caution. Various side effects such as dizziness, peripheral edema, headache, dyspepsia, etc. may occur, and if any unusual symptoms appear, consult a healthcare professional immediately. Avoid using this medication during pregnancy, and if pregnancy is confirmed, discontinue use as soon as possible and seek alternative treatment. Since blood pressure may drop too low, if symptoms of hypotension occur at the beginning of treatment, appropriate measures should be taken, and potassium levels and kidney function should be monitored regularly. This medication may interact with other drugs, so inform your doctor or pharmacist of any current medications. It is advisable for breastfeeding women to avoid taking this medication, and it is not recommended for children and adolescents as safety and efficacy have not been sufficiently established. In the case of overdose, symptoms such as hypotension, dizziness, and heart rate changes may occur, so immediate medical attention should be sought. This medication should be kept out of reach of children, stored in its sealed state, and transferred to other containers should be avoided.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light, so it should be kept in a container that is not exposed to light. Additionally, it is best to store the medication at room temperature between 1 and 30 degrees Celsius to maintain its effectiveness and safety.
Biconvex oval double-coated tablet in white and pale blue.
30 tablets/box [10 tablets/PTP*3], 30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Jinyang Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
ILDONG Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.